Identification of programmed cell death-related gene signature and associated regulatory axis in cerebral ischemia/reperfusion injury

被引:14
|
作者
Shu, Jun [1 ]
Yang, Lu [1 ]
Wei, Wenshi [1 ]
Zhang, Li [1 ]
机构
[1] Fudan Univ, Cognit Disorders Ctr, Dept Neurol, Huadong Hosp, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
apoptosis; pyroptosis; necroptosis; cerebral ischemia; reperfusion (I/R) injury; competing endogenous RNA (ceRNA) network; ISCHEMIA-REPERFUSION INJURY; INFLAMMASOME ACTIVATION; DOWN-REGULATION; LNCRNA MALAT1; NECROPTOSIS; APOPTOSIS; INHIBITION; STROKE; PROTEIN; NEUROPROTECTION;
D O I
10.3389/fgene.2022.934154
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Numerous studies have suggested that programmed cell death (PCD) pathways play vital roles in cerebral ischemia/reperfusion (I/R) injury. However, the specific mechanisms underlying cell death during cerebral I/R injury have yet to be completely clarified. There is thus a need to identify the PCD-related gene signatures and the associated regulatory axes in cerebral I/R injury, which should provide novel therapeutic targets against cerebral I/R injury. Methods: We analyzed transcriptome signatures of brain tissue samples from mice subjected to middle cerebral artery occlusion/reperfusion (MCAO/R) and matched controls, and identified differentially expressed genes related to the three types of PCD(apoptosis, pyroptosis, and necroptosis). We next performed functional enrichment analysis and constructed PCD-related competing endogenous RNA (ceRNA) regulatory networks. We also conducted hub gene analysis to identify hub nodes and key regulatory axes. Results: Fifteen PCD-related genes were identified. Functional enrichment analysis showed that they were particularly associated with corresponding PCD-related biological processes, inflammatory response, and reactive oxygen species metabolic processes. The apoptosis-related ceRNA regulatory network was constructed, which included 24 long noncoding RNAs (lncRNAs), 41 microRNAs (miRNAs), and 4 messenger RNAs (mRNAs); the necroptosis-related ceRNA regulatory network included 16 lncRNAs, 20 miRNAs, and 6 mRNAs; and the pyroptosis-related ceRNA regulatory network included 15 lncRNAs, 18 miRNAs, and 6 mRNAs. Hub gene analysis identified hub nodes in each PCD-related ceRNA regulatory network and seven key regulatory axes in total, namely, lncRNA Malat1/miR-181a-5p/Mapt, lncRNA Malat1/miR-181b-5p/Mapt, lncRNA Neat1/miR-181a-5p/Mapt, and lncRNA Neat1/miR-181b-5p/Mapt for the apoptosis-related ceRNA regulatory network; lncRNA Neat1/miR-181a-5p/Tnf for the necroptosis-related ceRNA regulatory network; lncRNA Malat1/miR-181c-5p/Tnf for the pyroptosis-related ceRNA regulatory network; and lncRNAMalat1/miR-181a-5p for both necroptosis-related and pyroptosis-related ceRNA regulatory networks. Conclusion: The results of this study supported the hypothesis that these PCD pathways (apoptosis, necroptosis, pyroptosis, and PANoptosis) and crosstalk among them might be involved in ischemic stroke and that the key nodes and regulatory axes identified in this study might play vital roles in regulating the above processes. This may offer new insights into the potential mechanisms underlying cell death during cerebral I/R injury and provide new therapeutic targets for neuroprotection.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Oxidative Stress and Inflammation Interaction in Ischemia Reperfusion Injury: Role of Programmed Cell Death
    Yao, Weifeng
    Tai, Lydia Wai
    Liu, Yiwei
    Hei, Ziqing
    Li, Haobo
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019
  • [22] Programmed cell death, from liver Ischemia-Reperfusion injury perspective: An overview
    Luo, Shaobin
    Luo, Rongkun
    Deng, Gang
    Huang, Feizhou
    Lei, Zhao
    HELIYON, 2024, 10 (13)
  • [23] Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer
    Kang, Zhen
    Sun, Jiang-Bo
    Lin, Fei
    Huang, Xu-Yun
    Huang, Qi
    Chen, Dong-Ning
    Zheng, Qing-Shui
    Xue, Xue-Yi
    Xu, Ning
    Wei, Yong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Management of ROS and Regulatory Cell Death in Myocardial Ischemia-Reperfusion Injury
    Gong, Ge
    Wan, Wenhui
    Zhang, Xinghu
    Chen, Xiangxuan
    Yin, Jian
    MOLECULAR BIOTECHNOLOGY, 2024, : 1765 - 1783
  • [25] Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
    Jiang, Silin
    Dong, Yuxiang
    Wang, Jun
    Zhang, Xi
    Liu, Wei
    Wei, Yong
    Zhou, Hai
    Shen, Luming
    Yang, Jian
    Zhu, Qingyi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [26] Potential of Edaravone Dexborneol in the treatment of cerebral ischemia: focus on cell death-related signaling pathways
    Rahmati-Dehkordi, Fatemeh
    Khanifar, Hadi
    Zare-Hoseinabadi, Alireza
    Dadgostar, Ehsan
    Jafarpour, Hamed
    Aschner, Michael
    Mirzaei, Hamed
    Tamtaji, Omid Reza
    Nabavizadeh, Fatemeh
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [27] An Immunogenic Cell Death-Related Gene Signature Predicts the Prognosis and Immune Infiltration of Cervical Cancer
    Sun, Fangfang
    Sun, Yuanyuan
    Tian, Hui
    CANCER INFORMATICS, 2025, 24
  • [28] An immunogenic cell death-related gene expression signature in predicting prognosis of pancreatic ductal adenocarcinoma
    Xiaobo Wang
    Tianxiang Ren
    Chuting Liao
    Yong Xie
    Jing Cao
    BMC Genomics, 25
  • [29] An immunogenic cell death-related gene expression signature in predicting prognosis of pancreatic ductal adenocarcinoma
    Wang, Xiaobo
    Ren, Tianxiang
    Liao, Chuting
    Xie, Yong
    Cao, Jing
    BMC GENOMICS, 2024, 25 (01)
  • [30] Immunogenomic profiles and therapeutic options of the pan-programmed cell death-related lncRNA signature for patients with bladder cancer
    Yang, Jia
    Zhang, Lusi
    Zhu, Bin
    Wu, Hongtao
    Peng, Mou
    SCIENTIFIC REPORTS, 2024, 14 (01):